ALZAMEND NEURO INC
ALZN·02262M605·US·Common Stock·Healthcare - Biotechnology-Activist
ALZN (ALZAMEND NEURO INC) is held by 7 institutional investors as of Q1 2026. Largest holders: GEODE CAPITAL MANAGEMENT, LLC ($48,420), VANGUARD FIDUCIARY TRUST CO ($22,281), MORGAN STANLEY ($19,080). Net institutional sentiment: Mixed.
7
Holders
Avg rating(1 Elite)
$105,227
Total Value
50% (10)
Fund Consensus
4 buying - 4 selling
Who's Trading
InsiderAIAULT MILTON C IIIBuy $109KApr 14, 2026
InsiderAIAULT MILTON C IIISell $4KDec 23, 2025
InsiderHBHorne William B.Sell $7KDec 19, 2025
InsiderMFMcGrath Lynne FaheySell $68.7Oct 23, 2025
InsiderAIAULT MILTON C IIISell $47KOct 9, 2025
InsiderAIAULT MILTON C IIISell $247KOct 8, 2025
ActivistMCMILTON C. AULT, III4.4%Oct 7, 2025
InsiderAIAULT MILTON C IIISell $143KOct 7, 2025
InsiderAIAULT MILTON C IIISell $201KOct 6, 2025
InsiderAIAULT MILTON C IIISell $161KOct 3, 2025
13F: Insider & Congress:
Continue exploring
Other Healthcare stocks held by institutions
LLYELI LILLY & CO
413 holders · $666.6B
UNHUNITEDHEALTH GROUP INC413 holders · $186.3B
JNJJOHNSON & JOHNSON394 holders · $391.3B
DHRDANAHER CORP DEL392 holders · $97B
ISRGINTUITIVE SURGICAL INC391 holders · $123.5B
TMOTHERMO FISHER SCIENTIFIC INC391 holders · $147B
BSXBOSTON SCIENTIFIC CORP389 holders · $76.8B
MRKMERCK & CO INC385 holders · $208.9B
ABBVABBVIE INC381 holders · $254.9B
ABTABBOTT LABORATORIES380 holders · $129.1B
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer